Filing Flows › NeuroPace (NPCE) › Q2 2025
NeuroPace (NPCE) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 12, 2025
NeuroPace (NPCE) reported revenue of $23.5M for the second quarter 2025 (Q2 2025), +22% from a year earlier and +4% from the quarter before. Operating margin was -29.0%, net loss $8.7M (36.8% of revenue).
NeuroPace, Q2 2025: revenue $23.5M (+22% year over year), operating margin -29.0%, net loss $8.7M, operating cash flow −$2.1M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $23.5M | +4% | +22% |
| Operating profit | −$6.8M | — | — |
| Net earnings | −$8.7M | — | — |
| Operating cash flow | −$2.1M | — | — |
What changed
Revenue was $23.5M in Q2 2025, up 22% year over year and up 4% from the previous quarter.
Gross margin was 77.1%, up 3.7 points from a year earlier. Operating costs exceeded revenue by $6.8M, an operating margin of -29.0%. Operating expenses grew 23% against revenue growth of 22%. The fastest-growing cost line was General & admin (+34%). The quarter ended with a net loss of $8.7M, wider than the previous quarter's $6.6M loss.
Operating cash flow was −$2.1M. Non-cash charges added back $100K of depreciation and $3.2M of share-based compensation. Working capital and other items added $3.2M. Capital expenditures of $168K exceeded it, leaving free cash flow of −$2.3M.
Questions
What was NeuroPace's revenue in the second quarter 2025?
NeuroPace (NPCE) reported revenue of $23.5M for the second quarter 2025 (Q2 2025), +22% from a year earlier and +4% from the quarter before.
Was NeuroPace profitable in the second quarter 2025?
Operating loss was $6.8M (-29.0% of revenue) and net loss $8.7M.
Source: NeuroPace 10-Q on SEC EDGAR.